DUKE Robotics (DUKR) Q2 2026 earnings summary

Executive summary

• Focused on advanced robotics and drone-based systems for military and civilian infrastructure, with key products including the IC Drone for insulator cleaning and the AEROTRACE aerial monitoring solution.

• Expanded 2026 IC Drone grid-maintenance season with Israel Electric Corporation, expected to generate over $1 million in revenue during 2026, and broadened operational footprint.

• New Bird of Prey drone order received through Elbit Systems, with deliveries and royalty revenue expected in 2026, and expanded collaboration for military drone technology.

• Completed $9.2 million underwritten public offering and uplisted to Nasdaq Capital Market, raising $7.3 million net.

• Appointed Yiftach Kleinman as incoming CEO to lead defense and commercial expansion, effective by September 8, 2026.

Financial highlights

• Revenues for Q2 2026 were $149,000, up from $143,000 in Q2 2025; most IEC contract revenue to be recognized later in 2026.

• Net loss for Q2 2026 was $726,000 ($0.26/share), compared to $269,000 ($0.12/share) in Q2 2025; net loss for the six months was $1,647,000 ($0.65/share), up from $548,000 ($0.25/share) in 2025, mainly due to one-time uplisting and offering expenses.

• Gross profit for Q2 2026 was $58,000, down from $88,000 in Q2 2025, due to higher depreciation and readiness costs.

• General and administrative expenses rose to $954,000 for Q2 2026, up from $314,000 in Q2 2025, reflecting uplisting, offering, and increased stock-based compensation.

• Cash and cash equivalents increased to $6,991,000 as of June 30, 2026, from $581,000 a year earlier, primarily due to net proceeds from the May 2026 public offering.

Outlook and guidance

• Majority of IEC contract revenue expected to be recognized in the remainder of 2026.

• Cash resources and projected receipts from existing agreements expected to support operations into 2028.

• Ongoing focus on expanding technology portfolio, operational scale, and international markets, with continued investment in R&D and commercialization.